Microbix Biosystems Inc. (MBXBF)
OTCMKTS · Delayed Price · Currency is USD
0.1800
+0.0015 (0.84%)
Aug 15, 2025, 3:35 PM EDT
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of $24.85 million as of August 15, 2025. Its market cap has decreased by -20.04% in one year.
Market Cap
24.85M
Enterprise Value
20.73M
Revenue
15.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 10.76M to 24.85M, an increase of 130.96%. That is a compound annual growth rate of 2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 24.85M | -35.10% |
| Dec 31, 2024 | 38.30M | -5.03% |
| Dec 29, 2023 | 40.33M | -4.23% |
| Dec 30, 2022 | 42.11M | -51.03% |
| Dec 31, 2021 | 85.98M | 136.92% |
| Dec 31, 2020 | 36.29M | 98.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 606.72M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 389.51M |
| Northwest Biotherapeutics | 351.78M |
| CytoDyn | 336.73M |